MRSN icon

Mersana Therapeutics

126 hedge funds and large institutions have $366M invested in Mersana Therapeutics in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 50 increasing their positions, 36 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$19K
Puts
$257K
Net Calls
Net Calls Change

Top Buyers

1 +$14.6M
2 +$9.89M
3 +$6M
4
BlackRock
BlackRock
New York
+$5.8M
5
SCM
Silverarc Capital Management
Massachusetts
+$3.93M

Top Sellers

1 -$4.21M
2 -$3.81M
3 -$3.18M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$2.89M
5
Morgan Stanley
Morgan Stanley
New York
-$2.76M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$41M
2
$40M
3
$34.9M
4
$21.9M
5
$20.2M
6
$19.9M
7
$18.8M
8
$18M
9
$14.6M
10
$10.2M
11
$9.2M
12
$9.14M
13
$8.6M
14
$7.49M
15
$7.27M
16
$7.26M
17
$5.2M
18
$5.02M
19
$4.84M
20
$4.18M
21
$3.96M
22
$3.93M
23
$3.03M
24
$2.63M
25
$2.49M